Phibro Animal Health (PAHC) Projected to Post Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is expected to post its Q4 2025 results before the market opens on Wednesday, August 27th. Analysts expect Phibro Animal Health to post earnings of $0.52 per share and revenue of $362.2410 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Wednesday, August 27, 2025 at 4:00 PM ET.

Phibro Animal Health Stock Up 1.9%

PAHC stock opened at $31.85 on Wednesday. The firm’s fifty day simple moving average is $27.86 and its 200-day simple moving average is $23.92. The company has a market capitalization of $1.29 billion, a P/E ratio of 40.83, a price-to-earnings-growth ratio of 0.52 and a beta of 0.80. The company has a debt-to-equity ratio of 2.67, a current ratio of 2.91 and a quick ratio of 1.23. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $32.08.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.5%. The ex-dividend date of this dividend is Wednesday, September 3rd. Phibro Animal Health’s dividend payout ratio is 61.54%.

Hedge Funds Weigh In On Phibro Animal Health

A number of large investors have recently added to or reduced their stakes in the stock. State of Wyoming raised its position in Phibro Animal Health by 148.8% during the second quarter. State of Wyoming now owns 6,608 shares of the company’s stock worth $169,000 after acquiring an additional 3,952 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of Phibro Animal Health by 768.2% during the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock worth $118,000 after buying an additional 4,079 shares in the last quarter. State of Tennessee Department of Treasury grew its holdings in shares of Phibro Animal Health by 18.6% during the second quarter. State of Tennessee Department of Treasury now owns 26,743 shares of the company’s stock worth $683,000 after buying an additional 4,200 shares in the last quarter. Oxford Asset Management LLP purchased a new stake in shares of Phibro Animal Health during the second quarter worth $485,000. Finally, Lazard Asset Management LLC grew its holdings in shares of Phibro Animal Health by 3,392.3% during the second quarter. Lazard Asset Management LLC now owns 92,441 shares of the company’s stock worth $2,360,000 after buying an additional 89,794 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the stock an “equal weight” rating in a report on Wednesday, June 25th. Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $25.00 to $35.00 in a report on Monday, July 7th. BNP Paribas raised shares of Phibro Animal Health to a “hold” rating in a report on Monday, June 16th. Finally, BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target on the stock in a report on Monday, June 16th. One analyst has rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $24.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.